Return to search results
Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone
Metabolite Input Files for Determining Biochemical Pathways Impacted by Spironolactone Exposures of Fathead Minnows (Pimephales promelas) Using the Mummichog Software package.
This dataset is associated with the following publication:
Davis, J., D. Skelton, D. Ekman, C. LaLone, G. Ankley, G. Ankley, J. Cavallin, D. Villeneuve, and T. Collette. Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone. AQUATIC TOXICOLOGY. Elsevier Science Ltd, New York, NY, USA, 184(0): 103-115, (2017).
Resources
1 resource available
-
Davis et al. 2017_Input Files.xlsx
APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.SPREADSHEETML.SHEET
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "020:00" ] |
| contactPoint |
{ "fn": "Drew Ekman", "hasEmail": "mailto:ekman.drew@epa.gov" } |
| describedBy | https://pasteur.epa.gov/uploads/10.23719/1378557/documents/Data%20Dictionary%20for%20Davis%20et%20al.%202017_Input%20File.docx |
| describedByType | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| description | Metabolite Input Files for Determining Biochemical Pathways Impacted by Spironolactone Exposures of Fathead Minnows (Pimephales promelas) Using the Mummichog Software package. This dataset is associated with the following publication: Davis, J., D. Skelton, D. Ekman, C. LaLone, G. Ankley, G. Ankley, J. Cavallin, D. Villeneuve, and T. Collette. Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone. AQUATIC TOXICOLOGY. Elsevier Science Ltd, New York, NY, USA, 184(0): 103-115, (2017). |
| distribution |
[ { "title": "Davis et al. 2017_Input Files.xlsx", "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1378557/Davis%20et%20al.%202017_Input%20Files.xlsx" } ] |
| identifier | https://doi.org/10.23719/1378557 |
| keyword |
[ "AOPs", "Mummichog", "mass spectrometry", "metabolomics", "spironolactone" ] |
| license | https://pasteur.epa.gov/license/sciencehub-license.html |
| modified | 2017-08-14 |
| programCode |
[ "020:095" ] |
| publisher |
{ "name": "U.S. EPA Office of Research and Development (ORD)", "subOrganizationOf": { "name": "U.S. Environmental Protection Agency", "subOrganizationOf": { "name": "U.S. Government" } } } |
| references |
[ "https://doi.org/10.1016/j.aquatox.2017.01.001" ] |
| rights |
null
|
| title | Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone |
